The clinical efficacy and safety of granulocyte and monocyte adsorptive apheresis in patients with Crohn's disease: A multicenter retrospective pilot study
Therapeutic Apheresis and Dialysis · 2024
DOI: 10.1111/1744-9987.14103 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Therapeutic Apheresis and Dialysis, 2024. Verfasst von Nobuhiro Ueno und 19 weiteren Autor:innen. Beteiligte Einrichtung: Division of General Medicine, Asahikawa Medical University Hospital, Asahikawa, Hokkaido, Japan. Hauptthemen laut MEDLINE: Crohn Disease, Monocytes, Granulocytes, Blood Component Removal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben.
Abstract (Originalsprache)
Introduction
A remission induction therapy of granulocyte and monocyte adsorptive apheresis (GMA) was given to patients with Crohn's disease (CD). However, establishing an appropriate treatment strategy for GMA in patients with CD remains unclear.
Methods
This study evaluated the clinical efficacy and subsequent clinical progression after GMA in patients with CD who underwent GMA in seven independent institutions in Japan from 2010 to 2023.
Results
Sixteen patients were enrolled. The overall remission and response rates were 25.0% and 68.8%, respectively. All patients responding to GMA received biologics that were continuously used and 36.4% of patients remained on the same biologics 52 weeks after GMA. Notably, all patients who continued the same biologics had previously experienced a loss of response to biologics.
Conclusion
GMA may exhibit effectiveness even in cases with refractory CD. Moreover, it represents a potential novel therapeutic option for refractory CD with loss of response to biologics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of General Medicine, Asahikawa Medical University Hospital, Asahikawa, Hokkaido, Japan.
- Department of Gastroenterological Sciences, Asahikawa Medical University, Asahikawa, Hokkaido, Japan.
- Furano Hospital, Furano, Hokkaido, Japan.
- Division of Gastroenterology, Department of Internal Medicine, Asahikawa Medical University, Asahikawa, Hokkaido, Japan.
- Nakashibetsu Town Hospital, Nakashibetsu, Hokkaido, Japan.
- Asahikawa Kosei General Hospital, Asahikawa, Hokkaido, Japan.
ORCID-Profile: Nobuhiro Ueno
Zitieren
APA
Ueno, N., Saito, S., Sato, M., Sugiyama, Y., Kobayashi, Y., Murakami, Y., Sugimura, K., Sasaki, T., Sakatani, A., Takahashi, K., Tanaka, K., Serikawa, S., Ando, K., Kashima, S., Muto, M., Inaba, Y., Moriichi, K., Tanabe, H., Okumura, T., & Fujiya, M. (2024). The clinical efficacy and safety of granulocyte and monocyte adsorptive apheresis in patients with Crohn's disease: A multicenter retrospective pilot study. Therapeutic Apheresis and Dialysis. https://doi.org/10.1111/1744-9987.14103
Vancouver
Ueno N, Saito S, Sato M, Sugiyama Y, Kobayashi Y, Murakami Y, et al. The clinical efficacy and safety of granulocyte and monocyte adsorptive apheresis in patients with Crohn's disease: A multicenter retrospective pilot study. Therapeutic Apheresis and Dialysis. 2024. doi:10.1111/1744-9987.14103
BibTeX
@article{Ueno2024,
author = {Ueno, Nobuhiro and Saito, Seisuke and Sato, Masahiro and Sugiyama, Yuya and Kobayashi, Yu and Murakami, Yuki and Sugimura, Kohjiro and Sasaki, Takahiro and Sakatani, Aki and Takahashi, Keitaro and Tanaka, Kazuyuki and Serikawa, Shinya and Ando, Katsuyoshi and Kashima, Shin and Muto, Momotaro and Inaba, Yuhei and Moriichi, Kentaro and Tanabe, Hiroki and Okumura, Toshikatsu and Fujiya, Mikihiro},
title = {The clinical efficacy and safety of granulocyte and monocyte adsorptive apheresis in patients with Crohn's disease: A multicenter retrospective pilot study},
journal = {Therapeutic Apheresis and Dialysis},
year = {2024},
doi = {10.1111/1744-9987.14103}
}
EUVIMED